Bank of New York Mellon
EXAS

Bank of New York Mellon’s Exact Sciences EXAS Stock Holding History

Bank of New York Mellon’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,000
Closed -$93K – 4281
2016
Q3 		$93K Buy
+5,000
New +$88.1K ﹤0.01% 4060

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Bank of New York Mellon's EXAS Position: Q1 2026 in Review

Bank of New York Mellon sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 620,376 shares — an estimated $63M sold.

Bank of New York Mellon first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $130M in Q2 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Bank of New York Mellon reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Bank of New York Mellon sold 620,376 Exact Sciences shares in Q1 2026, an estimated $63M.
  • Bank of New York Mellon first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Bank of New York Mellon's Exact Sciences position peaked at $130M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.